Polymorphic kinase anchor proteins and nucleic acids encoding the same

• US 6,958,214 B2
• Filed: 04/12/2001
• Issued: 10/25/2005
• Est. Priority Date: 07/10/2000
• Status: Expired due to Fees

• Current Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Braun, Andreas
• Primary Examiner(s): GOLDBERG, JEANINE ANNE
• Application Number:
  US09/834,700
• Publication Number:
  US 20020040130A1
• Time in Patent Office: 1,657 Days
• Field of Search: 536/23.1, 536/23.4, 536/24.3, 536/24.31, 536/24.33, 435/6, 435/91.2, 435/69.1, 435/320.1, 435/325, 435/174
• US Class Current: 435/6.16
• CPC Class Codes: C07K 14/003 Peptide-nucleic acids (PNAs)

Abstract

Polymorphic A-kinase anchor proteins (AKAPs) and nucleic acids encoding the proteins are provided herein. Methods of detecting polymorphic AKAPs and nucleic acids encoding the AKAPs, and kits for use in the detection methods are also provided. Further provided herein are methods of identifying subjects having or at risk of developing disorders of signal transduction. Methods of determining susceptibility to morbidity and/or increased or early mortality are also provided.

Claims

1. An isolated nucleic acid molecule, comprising a sequence of nucleotides that encodes a polypeptide of SEQ ID NO. 2, except that the Ile residue at position 646 of SEQ ID NO:

2 is replaced with Val, Leu or Phe.

2. An isolated nucleic acid molecule of claim 1, wherein the residue at position 646 of SEQ ID NO:

2 is Val.

3. An isolated nucleic acid molecule of claim 1, comprising the sequence of nucleotides set forth as position 138 to position 2126 of SEQ ID NO:

1, except that the nucleotide at position 2073 of SEQ ID NO;

1 is replaced with a nucleotide selected from the group consisting of G, T and C.

4. The nucleic acid molecule of claim 3, wherein the nucleotide at position 2073 of SEQ ID NO:

1 is G.

5. The isolated nucleic acid molecule of claim 2, comprising nucleotides from position 138 to position 2126 of SEQ ID NO:

3.

6. A nucleic acid vector, comprising the nucleic acid molecule of claim 1.

7. A cell containing the nucleic acid vector of claim 6.

10. The isolated nucleic acid molecule of claim 1, which consists essentially of the sequence of nucleotides that encodes the polypeptide of SEQ ID NO:

2.

11. A nucleic acid vector, which comprises the nucleic acid molecule of claim 10.

12. A cell containing the nucleic acid vector of claim 11.

13. The isolated nucleic acid molecule of claim 1, which consists of the sequence of nucleotides that encodes the polypeptide of SEQ ID NO:

2.

14. A nucleic acid vector, which comprises the nucleic acid molecule of claim 13.

15. A cell containing the nucleic acid vector of claim 13.

8. A cell which comprises a heterologous nucleic acid that encodes the sequence of amino acids set forth in SEQ ID NO:

4.

9. The cell of claim 8, wherein the nucleic acid comprises the sequence of nucleotides set forth from position 138 to position 2126 of SEQ. ID. NO:

3.